IL-33, acting via its receptor, ST2L, is a highly potent cytokine implicated in septic injury. The IL-33/ST2L axis appears indispensable in inflammatory signaling as blockade of the ST2L receptor significantly attenuates systemic inflammation. Thus, maneuvers designed to selectively modulate availability of ST2L might lessen the severity of sepsis. However, to date, very little is known regarding the molecular regulation of ST2L expression. In the process of studying bacterial sepsis, we discovered that a new orphan protein, FBXL19 (F-box protein 19, SCFFBXL19), specifically targets phosphorylated ST2L for its ubiquitination and degradation. Our published and preliminary works also shows that ST2L is phosphorylated by glycogen synthase kinase (GSK3?), and that activation of the IL-33/ST2L axis induces cleavage of PARP and PKC? thereby promoting apoptosis. Further, FBXL19 mediated disposal of ST2L attenuates IL-33/ST2L-induced pro-inflammatory signaling, apoptosis, and lessens the severity of inflammatory organ injury in septic murine models. These data led to our novel hypothesis that GSK3?-driven phosphorylation of ST2L serves as a molecular signature for F-box protein mediated ubiquitination and degradation of ST2L in sepsis-associated injury. We will test this hypothesis by executing two specific Aims: (1) To investigate the mechanisms by which GSK3? promotes ST2L degradation and regulates IL-33/ST2L signaling, and (2) To investigate the mechanisms by which FBXL19 and its ligand promotes ST2L ubiquitination and degradation thereby attenuating septic lung injury. These studies will lay the groundwork for a significant mechanistic advance with regard to the molecular regulation of a relatively new receptor (ST2L) involved in sepsis. Results from these studies are intended to serve as the basis for strategies directed at the development of novel small molecule inhibitors of the IL-33/ST2L pathway to lessen the severity of sepsis-induced organ injury.

Public Health Relevance

Acute lung injury (ALI) is a cause of respiratory failure resulting from acute pulmonary inflammation. Almost half of patients with septic shock develop ALI. These studies will identify molecular mechanisms on how a new protein, termed F-box protein FBXL19, targets a pro-inflammatory cytokine receptor to mediate its degradation. These studies will be critical in developing a novel small molecule as potential therapeutics to lessen the severity of sepsis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL112791-02
Application #
8666032
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Program Officer
Sarkar, Rita
Project Start
2013-06-01
Project End
2017-05-31
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
2
Fiscal Year
2014
Total Cost
$371,714
Indirect Cost
$126,714
Name
University of Pittsburgh
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Wei, Jianxin; Dong, Su; Bowser, Rachel K et al. (2017) Regulation of the ubiquitylation and deubiquitylation of CREB-binding protein modulates histone acetylation and lung inflammation. Sci Signal 10:
Cai, Junting; Culley, Miranda K; Zhao, Yutong et al. (2017) The role of ubiquitination and deubiquitination in the regulation of cell junctions. Protein Cell :
Nan, Ling; Jacko, Anastasia M; Tan, Jiangning et al. (2016) Ubiquitin carboxyl-terminal hydrolase-L5 promotes TGF?-1 signaling by de-ubiquitinating and stabilizing Smad2/Smad3 in pulmonary fibrosis. Sci Rep 6:33116
Zou, Chunbin; Synan, Matthew J; Li, Jin et al. (2016) LPS impairs oxygen utilization in epithelia by triggering degradation of the mitochondrial enzyme Alcat1. J Cell Sci 129:51-64
Barroso-González, J; Auclair, S; Luan, S et al. (2016) PACS-2 mediates the ATM and NF-?B-dependent induction of anti-apoptotic Bcl-xL in response to DNA damage. Cell Death Differ 23:1448-57
Nan, Ling; Wei, Jianxin; Jacko, Anastasia M et al. (2016) Cross-talk between lysophosphatidic acid receptor 1 and tropomyosin receptor kinase A promotes lung epithelial cell migration. Biochim Biophys Acta 1863:229-35
Jacko, A M; Nan, L; Li, S et al. (2016) De-ubiquitinating enzyme, USP11, promotes transforming growth factor ?-1 signaling through stabilization of transforming growth factor ? receptor II. Cell Death Dis 7:e2474
Zhao, Jing; Wei, Jianxin; Dong, Su et al. (2016) Destabilization of Lysophosphatidic Acid Receptor 1 Reduces Cytokine Release and Protects Against Lung Injury. EBioMedicine 10:195-203
Lendermon, Elizabeth A; Dodd-o, Jeffrey M; Coon, Tiffany A et al. (2015) CD8(+)IL-17(+) T Cells Mediate Neutrophilic Airway Obliteration in T-bet-Deficient Mouse Lung Allograft Recipients. Am J Respir Cell Mol Biol 52:622-33
Wei, Jianxin; Zhao, Jing; Schrott, Valerie et al. (2015) Red Blood Cells Store and Release Interleukin-33. J Investig Med 63:806-10

Showing the most recent 10 out of 30 publications